Side-by-side comparison of AI visibility scores, market position, and capabilities
New Delhi India YC W20 digital lending NBFC at INR 800Cr ($96M) revenue and INR 68Cr profit FY2024; $431M total at $800M valuation with INR 13,000Cr+ cumulative disbursals preparing for IPO competing with KreditBee.
Stashfin is a New Delhi, India-based digital lending fintech and NBFC (Non-Banking Financial Company) — backed by Y Combinator (W20) with $431 million in total funding (including significant debt financing) at an $800 million valuation as of June 2022 — providing instant personal loans, credit lines, and consumer credit products to underserved segments in India through a mobile-first digital lending platform. In FY2024, Stashfin generated INR 800 crore ($96 million) in revenue, INR 68 crore in net profit, and INR 2,000 crore in assets under management (AUM), while disbursing over INR 3,500 crore ($420 million) in loans in 2024 alone — with cumulative disbursals exceeding INR 13,000 crore ($1.56 billion) since inception. Founded in 2016, Stashfin is reportedly preparing for an IPO.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.